Eir Ventures grants one-carbon a convertible loan to continue pre-seed activities in company and at the same time Magnus Persson becomes the new chairman and Alexander Mata joins the board of directors.
One-carbon Therapeutics to Present Trial-in-Progress Poster on ODIN Phase 1/2 Study ofTH9619 at the 2026 ASCO Annual Meeting
Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage
